Aim & Scope

Journal of Blood Disorders and Therapeutics (JBDT) mainly focuses on all aspects of molecular genetics, pathophysiology and epidemiology as well as prevention, diagnosis, and management of blood disorders with current scenario of research in the field of transfusion medicine, hematology, blood components, acute myelogenous leukemia, stem Cell transplantation, neuropathy, blood donors, thalassemia, neutrophilic leukocytosis, anti-HBc, haemodilution, hemodialysis, blood stem cell, blood disorders, Rh factor, blood cancer, platelet disorders, hemolytic anemia, gene based therapeutics etc.

  • Transfusion Medicine
  • Stem Cell Transplantation
  • Apheresis
  • Gene Based Therapeutics
  • Blood Collection
  • Donor Issues
  • Blood banking logistics Immunohematology
  • Artificial and Alternative Blood Based Therapeutics
  • Blood banking
  • Acute lymphocytic and  myelogenous leukemia
  • Alpha thalassemia
  • Anemia
  • Splenectomy
  • Blood plasma
  • Chemotherapy
  • Coagulation disorders
  • Hematology
  • Hemolytic anemia
  • Leukapheresis
  • Neutropenia
  • Thrombectomy
  • Pulse Oximetry
  • Erythroblastosis
  • Myeloma
  • Blood hammer
  • Antiphospholide Antibody Syndrome
  • Autoimmune Haemolytic Anaemia
  • Blood Cancer
  • Blood Lymphocytes
  • Eosinophilia
  • Haemolytic Anaemia
  • Haemolytic Disease of the Newborn
  • Haemostasis
  • Juvenile Myelomonocytic Leukaemia
  • Leukopenia
  • Lupus
  • Lymphocytosis
  • Neutropenia
  • Neutrophilic Leukocytosis
  • Plasma Cell Disorder
  • Red Blood Cells
  • Sickle Cell Disease
  • Systematic Lupus Erythematous

Copyright © JBDT 2017.All right reserved.Created by Scholarena
Privacy Policy , Terms & Conditions